MORGAN RILEY: Open Payments
NPI 1164140695 · GEORGETOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,331 in 141 payments from 15 companies in 2025. Trend: 2023 $1,641 · 2024 $2,493 · 2025 $2,331
Food & beverage: $2,331
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $704 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 33 | $387 |
| Phathom Pharmaceuticals, Inc. | 23 | $305 |
| Janssen Biotech, Inc. | 21 | $226 |
| QOL Medical, LLC | 7 | $198 |
| Madrigal Pharmaceuticals | 4 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| GENZYME CORPORATION | 3 | $82 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Lilly USA, LLC | 2 | $44 |
Products named: RINVOQ, XIFAXAN, VOQUEZNA, TREMFYA, Sucraid, DUPIXENT, REZDIFFRA, ENTYVIO.
Industry payments across KY — which companies pay providers there.
